Examination of orbital tissues in murine models of graves' disease reveals expression of UCP-1 and the TSHR in retrobulbar adipose tissues

Hormone and Metabolic Research

Volumn 45, Issue 6, 2013, Pages 401-407

  Johnson, K T M ^a   Wiesweg, B ^a   Schott, M ^b   Ehlers, M ^b   Muller M ^a   Minich, W B ^c   Nagayama, Y ^d   Gulbins, E ^a   Eckstein, A K ^a   Berchner Pfannschmidt, U ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

animal model; brown adipose tissue; Graves' orbitopathy; macrophages

Indexed keywords

TETRAMER; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; UNCOUPLING PROTEIN 1;

ADENOVIRUS; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MACROPHAGE INFILTRATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RETROBULBAR ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GRAVES DISEASE; HUMANS; ION CHANNELS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; ORBIT; PROTEIN TRANSPORT; RECEPTORS, THYROTROPIN;

ADENOVIRIDAE; ANIMALIA; MURINAE; MUS;

EID: 84878526519     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1333224     Document Type: Article

References (37)

1. Eckstein A. K., Johnson K. T., Thanos M., Esser J., Ludgate M. Current insights into the pathogenesis of Graves' orbitopathy. Horm Metab Res: 2009; 41 456 464
2. Prabhakar B. S., Bahn R. S., Smith T. J. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev: 2003; 24 802 835
3. Bahn R. S. Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab: 2003; 88 1939 1946
4. Khoo D. H., Ho S. C., Seah L. L., Fong K. S., Tai E. S., Chee S. P., Eng P. H., Aw S. E., Fok A. C. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid: 1999; 9 1175 1180
5. Gerding M. N., van der Meer J. W., Broenink M., Bakker O., Wiersinga W. M., Prummel M. F. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf): 2000; 52 267 271
6. Noh J. Y., Hamada N., Inoue Y., Abe Y., Ito K. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid: 2000; 10 809 813
7. Eckstein A. K., Plicht M., Lax H., Neuhauser M., Mann K., Lederbogen S., Heckmann C., Esser J., Morgenthaler N. G. TSH-receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab: 2006; 91 3464 3470
8. Kaithamana S., Fan J., Osuga Y., Liang S. G., Prabhakar B. S. Induction of experimental autoimmune Graves' disease in BALB/c mice. J Immunol: 1999; 163 5157 5164
9. Shimojo N., Kohno Y., Yamaguchi K., Kikuoka S., Hoshioka A., Niimi H., Hirai A., Tamura Y., Saito Y., Kohn L. D., Tahara K. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA: 1996; 93 11074 11079
10. Costagliola S., Alcalde L., Tonacchera M., Ruf J., Vassart G., Ludgate M. Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R. Biochem Biophys Res Commun: 1994; 199 1027 1034
11. Costagliola S., Rodien P., Many M. C., Ludgate M., Vassart G. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol: 1998; 160 1458 1465
12. Nagayama Y. Animal models of Graves' hyperthyroidism. Endocr J: 2005; 52 385 394
13. Nagayama Y. Graves' animal models of Graves' hyperthyroidism. Thyroid: 2007; 17 981 988
14. Kita-Furuyama M., Nagayama Y., Pichurin P., McLachlan S. M., Rapoport B., Eguchi K. Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice. Clin Exp Immunol: 2003; 131 234 240
15. Yamaguchi K., Shimojo N., Kikuoka S., Hoshioka A., Hirai A., Tahara K., Kohn L. D., Kohno Y., Niimi H. Genetic control of anti-thyrotropin receptor antibody generation in H-2K mice immunized with thyrotropin receptor-transfected fibroblasts. J Clin Endocrinol Metab: 1997; 82 4266 4269
16. Nagayama Y., Kita-Furuyama M., Ando T., Nakao K., Mizuguchi H., Hayakawa T., Eguchi K., Niwa M. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol: 2002; 168 2789 2794
17. Saitoh O., Nagayama Y. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology: 2006; 147 2417 2422
18. Patibandla S. A., Fan J. L., Prabhakar B. S., Seetharamaiah G. S. Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor. J Autoimmun: 1999; 13 205 213
19. Land K. J., Gudapati P., Kaplan M. H., Seetharamaiah G. S. Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism. Endocrinology: 2006; 147 111 119
20. Seetharamaiah G. S., Land K. J. Differential Susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism. Thyroid: 2006; 16 651 658
21. Kaneda T., Honda A., Hakozaki A., Fuse T., Muto A., Yoshida T. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice. Endocrinology: 2007; 148 2335 2344
22. Many M. C., Costagliola S., Detrait M., Denef F., Vassart G., Ludgate M. C. Development of an animal model of autoimmune thyroid eye disease. J Immunol: 1999; 162 4966 4974
23. Ludgate M., Baker G. Inducing Graves' ophthalmopathy. J Endocrinol Invest: 2004; 27 211 215
24. Ludgate M. E. Animal models of thyroid-associated ophthalmopathy. Thyroid: 2002; 12 205 208
25. Ho S. C., Goh S. S., Kee I. H., Chow P. K., Yeo C. P., Khoo D. H. Effects of genetic immunization of Swiss outbred mice with human thyroid stimulating hormone receptor cDNA plasmids harboring gain-of-function mutations. J Mol Endocrinol: 2007; 38 277 288
26. Ulmer J. B., DeWitt C. M., Chastain M., Friedman A., Donnelly J. J., McClements W. L., Caulfield M. J., Bohannon K. E., Volkin D. B., Evans R. K. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine: 1999; 18 18 28
27. Andrew S. M., Titus J. A. Purification of immunoglobulin G. Curr Protoc Immunol: 2001; Chapter 2: Unit 27
28. Rammensee H., Bachmann J., Emmerich N. P., Bachor O. A., Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics: 1999; 50 213 219
29. Morgenthaler N. G., Ho S. C., Minich W. B. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites. J Clin Endocrinol Metab: 2007; 92 1058 1065
30. Mark M., Teletin M., Antal C., Wendling O., Auwerx J., Heikkinen S., Khetchoumian K., Argmann C. A., Dgheem M. Histopathology in mouse metabolic investigations. In: Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. (eds.). Current Protocols in Molecular Biology. Hoboken, N. J. Wiley: 2007; Chapter 29: Unit 29B 24
31. Payne A. P. The harderian gland: a tercentennial review. Journal of anatomy: 1994; 185 Pt 1 1 49
32. Baker G., Mazziotti G., von Ruhland C., Ludgate M. Reevaluating thyrotropin receptor-induced mouse models of Graves' disease and ophthalmopathy. Endocrinology: 2005; 146 835 844
33. Endo T., Kobayashi T. Thyroid-stimulating hormone receptor in brown adipose tissue is involved in the regulation of thermogenesis. American journal of physiology Endocrinology and metabolism: 2008; 295 E514 E518
34. Zhang L., Baker G., Janus D., Paddon C. A., Fuhrer D., Ludgate M. Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci: 2006; 47 5197 5203
35. Zhao S. X., Tsui S., Cheung A., Douglas R. S., Smith T. J., Banga J. P. Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA. J Endocrinol: 2011; 210 369 377
36. Ho S. C., Goh S. S., Su Q., Khoo D. H. Cysteine 390 mutation of the TSH receptor modulates its ectodomain as an inverse agonist on the serpentine domain with decrease in basal constitutive activity. Mol Cell Endocrinol: 2005; 245 158 168
37. Nakahara M., Johnson K., Eckstein A., Taguchi R., Yamada M., Abiru N., Nagayama Y. Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice. Endocrinology: 2012; 153 2034 2042